R&D Product Pipeline

ALG-801

Phase 1a and 1b clinical trials successfully completed 

Press Release. THOUSAND OAKS, Calif.--(BUSINESS WIRE)--"AliveGen Announces Successful Completion of Phase 1b Multiple-Ascending Dose Clinical Trial for ALG-801". March 18, 2024 08:00AM.  

https://www.businesswire.com/news/home/20240318622704/en/AliveGen-Announces-Successful-Completion-of-Phase-1b-Multiple-Ascending-Dose-Clinical-Trial-for-ALG-801

ALG-802

Preclinical and CMC development 

Multiple Novel Candidates

Preclinical development